
|Articles|February 2, 2022
Medable Acquires Mobile Applications from LEO Pharma
Advertisement
Medable Inc. announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company. Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. As part of the agreement with LEO Pharma A/S (owner of LEO Innovation Lab), Medable will take over the Omhu mobile applications and a team of 38 people with experience in digital health and artificial intelligence.
Read more about the acquisition
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
2
The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026
3
What the Epilepsy Community Has Taught Us About Trial Feasibility
4
Lab Orchestration Is Not What You Think It Is
5




